False positives with current carbocisteine protocol for sulphoxidation phenotyping
- 5 May 1990
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 335 (8697) , 1107
- https://doi.org/10.1016/0140-6736(90)92688-e
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The deficiency of sulfoxidation of S-Carboxymethyl-L-cysteinePharmacology & Therapeutics, 1989
- XENOBIOTIC METABOLISM IN MOTORNEURON DISEASEThe Lancet, 1988
- Poor sulphoxidation ability in patients with food sensitivity.BMJ, 1988
- High Incidence of Poor Sulfoxidation in Patients with Primary Biliary CirrhosisNew England Journal of Medicine, 1988
- SODIUM AUROTHIOMALATE TOXICITY AND SULPHOXIDATION CAPACITY IN RHEUMATOID ARTHRITIC PATIENTSRheumatology, 1987
- Lack of congruence ofS-carboxymethyl-L-cysteine sulphoxidation and debrisoquine 4-hydroxylation in a Caucasian populationXenobiotica, 1985
- Genetic aspects of the polymodally distributed sulphoxidation of S‐ carboxymethyl‐L‐cysteine in man.British Journal of Clinical Pharmacology, 1984
- Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in manBiochemical Pharmacology, 1982
- Excretion and Biotransformation of Carboxymethyl-cysteine in Rat, Dog, Monkey and ManXenobiotica, 1978